HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study.

AbstractOBJECTIVE:
The use of the new International Association of the Diabetes and Pregnancy Study Groups criteria (IADPSGC) for the diagnosis of gestational diabetes mellitus (GDM) results in an increased prevalence of GDM. Whether their introduction improves pregnancy outcomes has yet to be established. We sought to evaluate the cost-effectiveness of one-step IADPSGC for screening and diagnosis of GDM compared with traditional two-step Carpenter-Coustan (CC) criteria.
RESEARCH DESIGN AND METHODS:
GDM risk factors and pregnancy and newborn outcomes were prospectively assessed in 1,750 pregnant women from April 2011 to March 2012 using CC and in 1,526 pregnant women from April 2012 to March 2013 using IADPSGC between 24 and 28 weeks of gestation. Both groups received the same treatment and follow-up regimes.
RESULTS:
The use of IADPSGC resulted in an important increase in GDM rate (35.5% vs. 10.6%) and an improvement in pregnancy outcomes, with a decrease in the rate of gestational hypertension (4.1 to 3.5%: -14.6%, P < 0.021), prematurity (6.4 to 5.7%: -10.9%, P < 0.039), cesarean section (25.4 to 19.7%: -23.9%, P < 0.002), small for gestational age (7.7 to 7.1%: -6.5%, P < 0.042), large for gestational age (4.6 to 3.7%: -20%, P < 0.004), Apgar 1-min score <7 (3.8 to 3.5%: -9%, P < 0.015), and admission to neonatal intensive care unit (8.2 to 6.2%: -24.4%, P < 0.001). Estimated cost savings was of €14,358.06 per 100 women evaluated using IADPSGC versus the group diagnosed using CC.
CONCLUSIONS:
The application of the new IADPSGC was associated with a 3.5-fold increase in GDM prevalence in our study population, as well as significant improvements in pregnancy outcomes, and was cost-effective. Our results support their adoption.
AuthorsAlejandra Duran, Sofía Sáenz, María J Torrejón, Elena Bordiú, Laura Del Valle, Mercedes Galindo, Noelia Perez, Miguel A Herraiz, Nuria Izquierdo, Miguel A Rubio, Isabelle Runkle, Natalia Pérez-Ferre, Idalia Cusihuallpa, Sandra Jiménez, Nuria García de la Torre, María D Fernández, Carmen Montañez, Cristina Familiar, Alfonso L Calle-Pascual
JournalDiabetes care (Diabetes Care) Vol. 37 Issue 9 Pg. 2442-50 (Sep 2014) ISSN: 1935-5548 [Electronic] United States
PMID24947793 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
Topics
  • Adult
  • Diabetes, Gestational (diagnosis, economics)
  • Female
  • Follow-Up Studies
  • Gestational Age
  • Humans
  • Hypertension, Pregnancy-Induced (economics, prevention & control)
  • Mass Screening
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: